As researchers continue to investigate more effective and safe treatments, we MS patients will continue to read positive reports of clinical trial results and continue to hope for better treatments and possibly a cure someday. This week was one of those weeks. Positive results from a Phase IIb trial comparing alemtuzumab (Campath-1H) with interferon beta-1a (Rebif) was announced by Genzyme Corporation and Bayer HealthCare Pharmaceuticals.
Alemtuzumab is a DNA-derived humanized monoclonal...
“Cancer Drug Shows Promise Against Multiple Sclerosis.” Many of you have read this headline and wondered if this is the right... Read more »
Two recent developments in multiple sclerosis research offer renewed hope to patients. Hope that we will soon add new weapons to the... Read more »
In Monoclonal Antibodies: What Are They? we discussed a little bit about how T-cells and B-cells function within the immune system and how... Read more »
Have you ever considered participating in a clinical trial? I have, yet... I haven’t.ClinicalTrials.gov provides "patients, family... Read more »
Since I began writing for The Health Central Network in August of 2008, I have written 41 posts which makes today’s post #42. What have... Read more »
Source: ADAM Encyclopedia
CLL; Leukemia - chronic lymphocytic (CLL)TreatmentNo treatment is usually give for early stage CLL. However, the patient must be closely monitored by... Read more »
Source: ADAM Encyclopedia
ChemotherapyChemotherapy uses drugs to kill or alter cancer cells. Chemotherapy is not an effective initial treatment for low-grade brain tumors,... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
